ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

ReWalk Robotics Ltd.

Lifeward, previously known as ReWalk Robotics, develops and manufactures innovative solutions to change the lives of people with physical limitations or disabilities.

Lifeward

ReWalk Personal Exoskeleton

AlterG Anti-Gravity Systems

ReWalk Germany

Introducing Lifeward, previously ReWalk Robotics.
Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love.
As a global market leader in pioneering life-changing solutions, our portfolio features innovative products including the ReWalk Exoskeleton, the ReStore Exo-Suit, the MYOLYN FES bikes, and our newest addition, the AlterG Anti-Gravity systems. We will continue to be the driving force to elevate the standard of care in overcoming physical limitations and disabilities.
It’s not just upward. It’s Lifeward.

We're thrilled to share some exciting news with you. ReWalk Robotics has undergone a significant transformation and is now officially known as Lifeward. This rebranding reflects our unwavering commitment to empowerment, innovation, and life-changing solutions.

🌐 About Lifeward: More than a name change, Lifeward is a movement—a force dedicated to guiding individuals toward trajectories they never thought possible. At our core is the belief that life is a continuous journey of discovery, growth, and fulfillment. Lifeward sees itself as a trusted ally committed to helping people pursue their life ambitions in the face of physical challenges and disabilities.

🚀 Join us on this Journey: We've spent over a decade leading the industry with groundbreaking innovations, achieving the seemingly impossible. Now, as Lifeward, we're ready to shape a future filled with innovation, empowerment, and shared success.

👉 Follow Lifeward on LinkedIn: Stay connected for updates, inspiring stories, and the latest developments. Your support has been our driving force, and we can't wait to embark on this exciting chapter together.

Lifeward CEO Larry Jasinski chats with the Big Biz Show about the origination, future and Medicare coverage of the ReWalk Personal Exoskeleton, as well as highlighting the benefits and uses of AlterG Anti-Gravity Systems products. Thanks for having us 👏🎙️

Interested in how the recent Medicare reimbursement decision affects access to personal exoskeletons? Our upcoming TechTalk will provide info on how new developments will help the SCI/D community gain access to this technology. 

Join us in collaboration with Lifeward on August 29th: https://lnkd.in/e8EcNb6N

Hello, August! ☀️ This month we will be bouncing across the country for some amazing events. Will you be in the area or attending? If so, come on by and say hello! 🤗

Smiles all around at the Lifeward Mid-Year Sales Meeting! Launched the new AlterG NEO, rolled out the ReWalk S.T.A.R.T program, and had a blast at the baseball game - with a cupcake in hand of course! #TeamLifeward

In case you missed it: Lifeward CEO Larry Jasinski joins the conversation on the Big Biz Show to discuss Medicare coverage for the ReWalk Personal Exoskeleton, and the positive impact this will have on patients moving forward.

Did you know? Lifeward is your home for more than Exoskeletons and Anti-Gravity Treadmills. We have also been a proud US distributor of the MyoCycle FES Bikes since 2020, and the MyoCycle is a perfect example of how our solutions can span the continuum of care, delivering functional and health benefits in clinical settings as well as in the home and community. Learn more about FES cycling with the MyoCycle here: https://lnkd.in/gqnkpmec

We can't wait to see you this month during one of our in-person events we will be attending. Whether it is in Florida at ATAF or in New Orleans cheering on for the National Veterans Wheelchair Games, come say hi and learn about Lifeward's suite of innovative solutions. See you there! 🤗

Did you see the news? Hello, NEO!  
The latest innovation from Lifeward, the AlterG NEO is designed to elevate your practice and revolutionize patient care with its all-new user-friendly design and the same patented DAP technology for precise and consistent unweighting that is the cornerstone of every AlterG system.

This all-new FDA-listed Anti-Gravity Treadmill comes with a 21-inch display for an enhanced user experience, with new software and a more user-friendly touchscreen for seamless navigation and maximum training efficiency. The brand-new motorized cockpit adjustment allows for precise, customizable height adjustments at the push of a button, and the 120V power source simplifies installation and integration into your practice. The 23-inch handrail width ensures comfort and support for patients and athletes of all body types, including neuro, ortho, and weight-loss applications. And the best part? The AlterG NEO comes at the most cost-effective pricing to date.

NEO helps you deliver results for your patients and clients at a price point that is right for you, on an Anti-Gravity treadmill that is right for them. Get ready to elevate your clinical practice - starting today! alterg.com

🌟 We're thrilled to unveil the AlterG NEO by Lifeward! 🌟 This FDA-listed Anti-Gravity Treadmill is designed to transform patient care with its advanced features: an expansive 21-inch display for an enhanced user experience, motorized cockpit adjustments for precise height adjustments at the push of a button, a 23-inch handrail for optimal comfort, and a convenient 120V power source. Best of all, it's more cost-effective than ever before, making the patented AlterG Anti-Gravity technology accessible to every practice. Discover how the AlterG NEO can elevate your training and patient care. alterg.com

	Dec '21	Dec '22	Dec '23
net income	-12.74M -	-19.57M 53.65%	-22.13M 13.10%
depreciation and amortization	266K -	202K 24.06%	1.85M 814.36%
deferred income tax	-29K -	316K 1,189.66%	-45K 114.24%
stock based compensation	833K -	993K 19.21%	1.33M 33.74%
change in working capital	197K -	88K 55.33%	-1.34M 1,620.45%
accounts receivables	99K -	-408K 512.12%	-311K 23.77%
inventory	432K -	-117K 127.08%	-277K 136.75%
accounts payables	-884K -	566K 164.03%	1.04M 83.22%
other working capital	550K -	47K 91.45%	-1.79M 3,902.13%
other non cash items		79K -	-326K 512.66%
net cash provided by operating activities	-11.47M -	-17.89M 55.99%	-20.67M 15.52%
investments in property plant and equipment	-47K -	-25K 46.81%	-81K 224.00%
acquisitions net			-18.07M -
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites	-47K -	-25K 46.81%	-18.15M 72,496%
debt repayment
common stock issued	64.45M -
common stock repurchased		-2.50M -	-992K 60.32%
dividends paid
other financing activites
net cash used provided by financing activities	79.51M -	-2.50M 103.14%	-992K 60.32%
effect of forex changes on cash		-79K -	45K 156.96%
net change in cash	68.00M -	-20.50M 130.14%	-39.76M 94.01%
cash at beginning of period	21.05M -	89.05M 322.96%	68.56M 23.02%
cash at end of period	89.05M -	68.56M 23.02%	28.79M 58.00%
operating cash flow	-11.47M -	-17.89M 55.99%	-20.67M 15.52%
capital expenditure	-47K -	-25K 46.81%	-81K 224.00%
free cash flow	-11.52M -	-17.92M 55.57%	-20.75M 15.81%

COM:GOLIFEWARD

Lifeward

Last Close

2.45

25/10 20:00

Market Cap

33.98M

Beta: -

Volume Today

17.05K

Avg: -

Preview